**1. Financial Highlights:** Q1 FY26 saw revenue up 11% YoY to ₹116.9 Cr.

EBITDA jumped 37% to ₹17.3 Cr (14.8% margin), and PAT grew 28% to ₹6.7 Cr (5.7% margin). While FY25 revenue slightly dipped and PAT dropped significantly, the balance sheet indicates low net debt. **2. Strategic Initiatives & Growth Drivers:** The company emphasizes 'green' chemistry (electrolysis, continuous flow chemistry) supported by R&D. Its diversified product portfolio (PTC, SDA, Electrolyte Salts, PASC) and substantial exports (62% of FY25 revenue) drive growth and minimize market reliance. **3. Business Developments:** PASC became the largest revenue contributor in Q1 FY26 (37%). Global expansion continues via USA and Netherlands subsidiaries and warehousing facilities, enhancing international operations. **4. Market Position & Competitive Advantage:** A niche specialty chemicals leader, Tatva Chintan holds top positions in key product segments.

High entry barriers and proprietary green technology create a strong moat, leveraging the 'China+1' market shift. **5. Investor Implications:** Q1 FY26's robust rebound signals positive growth potential.

The strategic focus on sustainable chemistry and high-barrier products supports long-term prospects.

Sustained execution will be key.